WO2010079506A3 - Pharmaceutical composition of aripiprazole - Google Patents

Pharmaceutical composition of aripiprazole Download PDF

Info

Publication number
WO2010079506A3
WO2010079506A3 PCT/IN2009/000356 IN2009000356W WO2010079506A3 WO 2010079506 A3 WO2010079506 A3 WO 2010079506A3 IN 2009000356 W IN2009000356 W IN 2009000356W WO 2010079506 A3 WO2010079506 A3 WO 2010079506A3
Authority
WO
WIPO (PCT)
Prior art keywords
aripiprazole
pharmaceutical composition
present
solid oral
oral pharmaceutical
Prior art date
Application number
PCT/IN2009/000356
Other languages
French (fr)
Other versions
WO2010079506A2 (en
Inventor
Rakesh Sheth
Original Assignee
Torrent Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torrent Pharmaceuticals Ltd. filed Critical Torrent Pharmaceuticals Ltd.
Publication of WO2010079506A2 publication Critical patent/WO2010079506A2/en
Publication of WO2010079506A3 publication Critical patent/WO2010079506A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to stable, solid oral pharmaceutical composition comprising aripiprazole manufactured by wet granulation, wherein intragranular stage is devoid of diluent. The present invention further relates to processes for the preparation of said solid oral pharmaceutical composition of aripiprazole.
PCT/IN2009/000356 2008-06-23 2009-06-22 Pharmaceutical composition of aripiprazole WO2010079506A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1302/MUM/2008 2008-06-23
IN1302MU2008 2008-06-23

Publications (2)

Publication Number Publication Date
WO2010079506A2 WO2010079506A2 (en) 2010-07-15
WO2010079506A3 true WO2010079506A3 (en) 2010-09-10

Family

ID=42272511

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000356 WO2010079506A2 (en) 2008-06-23 2009-06-22 Pharmaceutical composition of aripiprazole

Country Status (1)

Country Link
WO (1) WO2010079506A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR201000948A1 (en) * 2010-02-09 2011-08-22 Sanovel İlaç San.Ve Ti̇c.A.Ş. Aripiprazole formulations.
WO2013100878A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Pharmaceutical formulations comprising aripiprazole
WO2014104989A1 (en) * 2011-12-27 2014-07-03 Mahmut Bilgic Pharmaceutical compositions comprising aripiprazole
TW201343201A (en) * 2012-03-06 2013-11-01 Otsuka Pharma Co Ltd Sustained release oral solid preparation
WO2013175508A2 (en) * 2012-05-24 2013-11-28 Medreich Limited Stable pharmaceutical composition of aripiprazole

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257471A1 (en) * 2005-03-17 2006-11-16 Ettema Gerrit J Pharmaceutical tablets of crystalline Type II aripiprazole
WO2007081366A1 (en) * 2006-01-05 2007-07-19 Teva Pharmaceutical Industries Ltd. Wet granulation pharmaceutical compositions of aripiprazole
WO2007081367A1 (en) * 2006-01-05 2007-07-19 Teva Pharmaceutical Industries Ltd. Dry formulations of aripiprazole

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
AR033485A1 (en) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd MEDICINAL SUBSTANCE OF ARIPIPRAZOL OF LOW HYGROSCOPICITY AND PROCESS FOR THE PREPARATION OF THE SAME

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060257471A1 (en) * 2005-03-17 2006-11-16 Ettema Gerrit J Pharmaceutical tablets of crystalline Type II aripiprazole
WO2007081366A1 (en) * 2006-01-05 2007-07-19 Teva Pharmaceutical Industries Ltd. Wet granulation pharmaceutical compositions of aripiprazole
WO2007081367A1 (en) * 2006-01-05 2007-07-19 Teva Pharmaceutical Industries Ltd. Dry formulations of aripiprazole

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
AOKI S ET AL: "Study on Crystal Transformation of ARIPIPRAZOL", 19961006, 6 October 1996 (1996-10-06), pages 937 - 940, XP002970982 *

Also Published As

Publication number Publication date
WO2010079506A2 (en) 2010-07-15

Similar Documents

Publication Publication Date Title
WO2010092090A3 (en) Novel salts of sitagliptin
WO2010049454A3 (en) Antimicrobial composition from copepods
WO2009085990A3 (en) Processes for the preparation of sitagliptin and pharmaceutically acceptable salts thereof
WO2008127646A8 (en) Transaminase-based processes for preparation of pregabalin
WO2009104021A3 (en) Novel polymorphs and processes for their preparation
WO2010117738A3 (en) Solid state forms of sitagliptin salts
WO2008149345A3 (en) Tri-aryl compounds and compositions comprising the same
WO2010139981A3 (en) Processes for preparing crystalline forms of dasatinib
GEP20156328B (en) Solid pharmaceutical compositions and processes for their production
WO2012025944A3 (en) Sitagliptin, salts and polymorphs thereof
WO2012070062A3 (en) Novel polymorph of nilotinib hydrochloride
WO2010049449A3 (en) Novel salts of sunitinib
WO2009094457A3 (en) Substituted benzhydrylethers
CL2007003875A1 (en) COMPOUNDS DERIVED FROM AMIDAS OF THE 3-AMINO TETRAHYDROFURAN-3-CARBOXYL ACID; PROCEDURE FOR PREPARATION OF SUCH COMPOUNDS.
WO2008129501A3 (en) Pharmaceutical compositions of duloxetine
EP2666765A3 (en) Process for the preparation of substituted 3-(1-amino-2-methyl-pentane-3-yl)phenyl compounds
WO2012137227A3 (en) Solid forms of antiretroviral compounds and anti-oxidative acids, processes for preparation and pharmaceutical compositions thereof
WO2010079506A3 (en) Pharmaceutical composition of aripiprazole
WO2012075015A3 (en) Oral metronidazole pharmaceutical compositions
WO2008073863A3 (en) Preparation and utility of substituted allylamines
WO2010079045A3 (en) Crystalline salt forms of flibanserine
WO2011069032A3 (en) Formulations, salts and polymorphs of transnorsertraline and uses thereof
WO2010015656A3 (en) Alkoxypyrazoles and the process for their preparation
WO2010006904A3 (en) Crystalline forms of rabeprazole sodium
WO2008049922A3 (en) A new process for the preparation of montelukast

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09828418

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 09828418

Country of ref document: EP

Kind code of ref document: A2